A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
一项评估阿福替沙林和5-氟尿嘧啶联合奥沙利铂（加或不加贝伐珠单抗）或伊立替康治疗转移性结直肠癌的I/II期临床研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100589
Carlsson, G; Koumarianou, A; Guren, T K; Haux, J; Katsaounis, P; Kentepozidis, N; Pfeiffer, P; Brændengen, M; Mavroudis, D; Taflin, H; Skintemo, L; Tell, R; Papadimitriou, C
